Accustem Sciences Inc. (ACUT) stock
ACUTOTCPharmaceutical PreparationsFiscal year ends December 31
$0.15+0.00 (0.00%)
Close on Oct 16, 2026Market cap $2.37MP/E –Yield –
Accustem Sciences operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Accustem Sciences's operating cash flow for the twelve months ending Jun 30, 2026 was -$1.20M. For fiscal 2025 it was -$850.39K.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$850.39K | – |
| FY2024 | Dec 31, 2024 | -$664.07K | – |
| FY2023 | Dec 31, 2023 | -$1.62M | – |
| FY2022 | Dec 31, 2022 | -$1.81M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$248.85K | -1253.8% |
| Q1 FY2026 | Mar 31, 2026 | -$374.18K | – |
| Q4 FY2025 | Dec 31, 2025 | $22.36K | +5300.2% |
| Q3 FY2025 | Sep 30, 2025 | -$604.13K | – |
| Q2 FY2025 | Jun 30, 2025 | $21.57K | – |
| Q1 FY2025 | Mar 31, 2025 | -$290.18K | – |
| Q4 FY2024 | Dec 31, 2024 | $414 | – |
| Q3 FY2024 | Sep 30, 2024 | -$217.95K | – |
| Q2 FY2024 | Jun 30, 2024 | -$209.18K | – |
| Q1 FY2024 | Mar 31, 2024 | -$237.35K | – |
| Q4 FY2023 | Dec 31, 2023 | -$295.03K | – |
| Q3 FY2023 | Sep 30, 2023 | -$351.61K | – |
| Q2 FY2023 | Jun 30, 2023 | -$522.91K | – |
| Q1 FY2023 | Mar 31, 2023 | -$446.09K | -219.9% |
| Q4 FY2022 | Dec 31, 2022 | -$622.26K | – |
| Q3 FY2022 | Sep 30, 2022 | -$555.29K | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.00M | – |
| Q1 FY2022 | Mar 31, 2022 | $371.98K | – |
See a number that looks wrong?